Obeticholic acid in primary biliary cholangitis: PBC OCA international study of efficacy (POISE);Obeticholsäure bei primär biliärer Cholangitis: PBC OCA International Study of Efficacy (POISE)

Internist

Volumn 58, Issue 2, 2017, Pages 202-204

  Gerken, G ^a   Nitschmann, S ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OBETICHOLIC ACID; CHENODEOXYCHOLIC ACID;

ARTICLE; CHOLANGITIS; PRIMARY BILIARY CHOLANGITIS; ANALOGS AND DERIVATIVES; HUMAN;

CHENODEOXYCHOLIC ACID; CHOLANGITIS; HUMANS;

EID: 85010734912     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-016-0185-9     Document Type: Article

References (3)

1. Yimam KK, Bowlus CL (2014) Obeticholic acid for the treatment of primary biliary cirrhosis. Expert Opin Orphan Drugs 2:1351–1358
2. Trivedi PJ, Hirschfield GM, Gershwin ME (2015) Obeticholic acid for the treatment of primary biliary cirrhosis. Expert Ref Clin Pharmacol 9:1–14
3. Nevens F et al for the POISE Study Group (2016) A placebo-controlled trial of obeticholic acid in primary biliary chonangitis. New Engl J Med 375:631−643